Top companies on the NasdaqGS by Price to Sales Ratio (P/S)

This ranking features the top 1,075 companies on the NasdaqGS ranked by Price to Sales Ratio (P/S), averaging a Price to Sales Ratio (P/S) of 52.21, for January 15, 2025.

NasdaqGS

All sectors

#	Name	Price to Sales Ratio (P/S)	Reported Date	Stock Price	Change	Country
1	Revolution Medicines, Inc. 1 RVMD	9,919.66	Jan. 14, 2025	USD 39.83	-6.44%	United States
2	Allogene Therapeutics, Inc. 2 ALLO	9,362.10	Jan. 14, 2025	USD 1.92	-1.54%	United States
3	Akero Therapeutics, Inc. 3 AKRO	5,375.03	Jan. 14, 2025	USD 21.87	-3.36%	United States
4	Crinetics Pharmaceuticals, Inc. 4 CRNX	3,179.32	Jan. 14, 2025	USD 35.62	-8.62%	United States
5	AST SpaceMobile, Inc. 5 ASTS	2,373.51	Jan. 14, 2025	USD 20.48	-2.80%	United States
6	Enliven Therapeutics, Inc. 6 ELVN	2,271.95	Jan. 14, 2025	USD 20.46	-7.29%	United States
7	Immunovant, Inc. 7 IMVT	2,238.96	Jan. 14, 2025	USD 22.88	0.57%	United States
8	Quince Therapeutics, Inc. 8 QNCX	2,090.08	Jan. 14, 2025	USD 1.71	-1.16%	United States
9	Cytokinetics, Incorporated 9 CYTK	1,658.21	Jan. 14, 2025	USD 45.23	-3.17%	United States
10	Tyra Biosciences, Inc. 10 TYRA	1,606.80	Jan. 14, 2025	USD 15.94	5.56%	United States
11	Acelyrin, Inc. 11 SLRN	1,269.18	Jan. 14, 2025	USD 2.10	-2.33%	United States
12	Spyre Therapeutics, Inc. 12 SYRE	1,203.69	Jan. 14, 2025	USD 20.80	-3.48%	United States
13	Edgewise Therapeutics, Inc. 13 EWTX	1,157.12	Jan. 14, 2025	USD 27.52	8.65%	United States
14	Praxis Precision Medicines, Inc. 14 PRAX	764.56	Jan. 14, 2025	USD 65.84	2.84%	United States
15	Vaxcyte, Inc. 15 PCVX	674.18	Jan. 14, 2025	USD 78.14	-3.73%	United States
16	Arrowhead Pharmaceuticals, Inc. 16 ARWR	632.51	Jan. 14, 2025	USD 18.05	-4.55%	United States
17	IDEAYA Biosciences, Inc. 17 IDYA	501.01	Jan. 14, 2025	USD 22.74	-1.00%	United States
18	AN2 Therapeutics, Inc. 18 ANTX	455.65	Jan. 14, 2025	USD 1.22	-3.17%	United States
19	ORIC Pharmaceuticals, Inc. 19 ORIC	454.69	Jan. 14, 2025	USD 9.91	15.23%	United States
20	Kura Oncology, Inc. 20 KURA	444.54	Jan. 14, 2025	USD 7.26	0.28%	United States
21	Dyne Therapeutics, Inc. 21 DYN	402.98	Jan. 14, 2025	USD 15.00	-1.90%	United States
22	Scholar Rock Holding Corporation 22 SRRK	333.43	Jan. 14, 2025	USD 41.53	-2.51%	United States
23	Acumen Pharmaceuticals, Inc. 23 ABOS	323.19	Jan. 14, 2025	USD 1.56	-1.89%	United States
24	Terns Pharmaceuticals, Inc. 24 TERN	293.62	Jan. 14, 2025	USD 4.57	-4.79%	United States
25	Design Therapeutics, Inc. 25 DSGN	271.62	Jan. 14, 2025	USD 4.02	-2.19%	United States
26	ImmunityBio, Inc. 26 IBRX	231.04	Jan. 14, 2025	USD 2.32	-6.45%	United States
27	Tourmaline Bio, Inc. 27 TRML	209.56	Jan. 14, 2025	USD 18.60	-4.47%	United States
28	Olema Pharmaceuticals, Inc. 28 OLMA	202.55	Jan. 14, 2025	USD 5.14	6.20%	United States
29	Replimune Group, Inc. 29 REPL	199.72	Jan. 14, 2025	USD 10.49	-3.67%	United States
30	MicroStrategy Incorporated 30 MSTR	180.51	Jan. 14, 2025	USD 342.17	4.19%	United States
31	Cogent Biosciences, Inc. 31 COGT	145.69	Jan. 14, 2025	USD 7.37	-2.64%	United States
32	Pliant Therapeutics, Inc. 32 PLRX	141.32	Jan. 14, 2025	USD 11.24	-4.50%	United States
33	Ventyx Biosciences, Inc. 33 VTYX	127.49	Jan. 14, 2025	USD 1.94	-0.51%	United States
34	Inhibrx Biosciences, Inc. 34 INBX	106.36	Jan. 14, 2025	USD 12.74	-6.60%	United States
35	Annexon, Inc. 35 ANNX	99.23	Jan. 14, 2025	USD 4.53	-8.30%	United States
36	Erasca, Inc. 36 ERAS	97.54	Jan. 14, 2025	USD 1.93	-10.23%	United States
37	Enovix Corporation 37 ENVX	95.93	Jan. 14, 2025	USD 10.56	-4.00%	United States
38	Arbutus Biopharma Corporation 38 ABUS	89.38	Jan. 14, 2025	USD 3.18	-5.08%	United States
39	Madrigal Pharmaceuticals, Inc. 39 MDGL	77.06	Jan. 14, 2025	USD 274.12	-9.74%	United States
40	Absci Corporation 40 ABSI	73.99	Jan. 14, 2025	USD 2.71	-4.91%	United States
41	Astera Labs, Inc. Common Stock 41 ALAB	66.64	Jan. 14, 2025	USD 128.45	0.99%	United States
42	Syndax Pharmaceuticals, Inc. 42 SNDX	65.04	Jan. 14, 2025	USD 12.60	-1.56%	United States
43	Geron Corporation 43 GERN	60.29	Jan. 14, 2025	USD 2.94	-1.34%	United States
44	Agios Pharmaceuticals, Inc. 44 AGIO	57.81	Jan. 14, 2025	USD 33.32	-2.86%	United States
45	Palantir Technologies Inc. 45 PLTR	56.74	Jan. 14, 2025	USD 65.91	1.43%	United States
46	PepGen Inc. 46 PEPG	53.41	Jan. 14, 2025	USD 2.72	-2.86%	United States
47	Humacyte, Inc. 47 HUMA	49.13	Jan. 14, 2025	USD 4.12	-6.15%	United States
48	Inozyme Pharma, Inc. 48 INZY	49.09	Jan. 14, 2025	USD 1.51	-12.21%	United States
49	Credo Technology Group Holding Ltd 49 CRDO	47.25	Jan. 14, 2025	USD 69.39	0.51%	United States
50	PMV Pharmaceuticals, Inc. 50 PMVP	43.18	Jan. 14, 2025	USD 1.35	-2.88%	United States

1 2 3 4 … 22

Frequently Asked Questions

Which company on the NasdaqGS has the highest Price to Sales Ratio (P/S) ?

The company on the NasdaqGS with the highest Price to Sales Ratio (P/S) is Revolution Medicines, Inc. (NasdaqGS: RVMD) at 9,919.66.
Which company on the NasdaqGS has the lowest Price to Sales Ratio (P/S) ?

The company on the NasdaqGS with the lowest Price to Sales Ratio (P/S) is Comtech Telecommunications Corp. (NasdaqGS: CMTL) at 0.00.

What are the top 10 companies on the NasdaqGS by Price to Sales Ratio (P/S) ?

The top 10 companies on the NasdaqGS by Price to Sales Ratio (P/S) are Revolution Medicines, Inc., Allogene Therapeutics, Inc., Akero Therapeutics, Inc., Crinetics Pharmaceuticals, Inc., AST SpaceMobile, Inc., Enliven Therapeutics, Inc., Immunovant, Inc., Quince Therapeutics, Inc., Cytokinetics, Incorporated and Tyra Biosciences, Inc..
What are the bottom 10 companies on the NasdaqGS by Price to Sales Ratio (P/S) ?

The bottom 10 companies on the NasdaqGS by Price to Sales Ratio (P/S) are Comtech Telecommunications Corp., ModivCare Inc., StoneX Group Inc., Kirkland's, Inc., Big 5 Sporting Goods Corporation, Sonder Holdings Inc., SpartanNash Company, A-Mark Precious Metals, Inc., Sportsman's Warehouse Holdings, Inc. and Walgreens Boots Alliance, Inc..